Michael Eisenstein
Freelance Writer
Nature
From this contributor
Treatments: In the waiting room
After years of making do with drugs developed for other conditions, doctors and scientists are eagerly pursuing drugs that target the social symptoms of autism.
Explore more from The Transmitter
Null and Noteworthy: Learning theory validated 20 years later
The first published paper from the EEGManyLabs replication project nullifies a null result that had complicated a famous reinforcement learning theory.
Null and Noteworthy: Learning theory validated 20 years later
The first published paper from the EEGManyLabs replication project nullifies a null result that had complicated a famous reinforcement learning theory.
Neuroscientist Gerry Fischbach, in his own words
In 2023, I had the privilege of sitting down with Gerry over the course of several days and listening as he told the story of his life and career—including stints as dean or director of such leading institutions as Columbia University and NINDS—so that we could record it for posterity.
Neuroscientist Gerry Fischbach, in his own words
In 2023, I had the privilege of sitting down with Gerry over the course of several days and listening as he told the story of his life and career—including stints as dean or director of such leading institutions as Columbia University and NINDS—so that we could record it for posterity.
Amina Abubakar translates autism research and care for Kenya
First an educator and now an internationally recognized researcher, the Kenyan psychologist is changing autism science and services in sub-Saharan Africa.
Amina Abubakar translates autism research and care for Kenya
First an educator and now an internationally recognized researcher, the Kenyan psychologist is changing autism science and services in sub-Saharan Africa.